Glycaemic control in Australia and New Zealand before and after the NICE-SUGAR trial: a translational study

Kirsi-Maija Kaukonen, Michael John Bailey, David V Pilcher, Neil Orford, Simon Finfer, Rinaldo Bellomo

Research output: Contribution to journalArticleResearchpeer-review

13 Citations (Scopus)


There is no information on the uptake of Intensive Insulin Therapy (IIT) before the NICE-SUGAR trial in Australia and New Zealand (ANZ) and on the bi-national response to the trial, yet such data would provide important information on the evolution of ANZ practice in this field. We aimed to study ANZ glycaemic control before and after the publication of the results of the NICE-SUGAR trial. Methods: We analysed glucose control in critically ill patients across Australia and New Zealand during a 2 year period before and after the publication of the Normoglycemia in Intensive Care Evaluation and Surviving Using Glucose Algorithm Regulation (NICE-SUGAR) study. We used the mean 1st day glucose (Glu1) (a validated surrogate of ICU glucose control) to define practice. The implementation of an IIT protocol was presumed if the median of Glu1 measurements was 48/
Original languageEnglish
Pages (from-to)1 - 10
Number of pages10
JournalCritical Care
Issue number5 (Art. ID: R215)
Publication statusPublished - 2013

Cite this